Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Diagnostic Medical Systems ( (FR:ALDMS) ) just unveiled an announcement.
Diagnostic Medical Systems reported a 9% revenue increase for 2024, reaching €46.1 million, driven by solid growth in its core Radiology and Bone Densitometry sectors. The company is benefiting from international commercial momentum, particularly in African and Asian markets, which contributed significantly to its sales growth, although its European market remained stable.
More about Diagnostic Medical Systems
Diagnostic Medical Systems (DMS Group) specializes in high-performance medical imaging systems, focusing on Digital Radiology and Bone Densitometry. The company is known for its strategic emphasis on innovations in imaging solutions, supported by a strong distributor network and OEM agreements.
YTD Price Performance: 1.29%
Technical Sentiment Consensus Rating: Buy
Current Market Cap: €13.21M
For detailed information about ALDMS stock, go to TipRanks’ Stock Analysis page.
